BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Veerabhadrappa B, Delaby C, Hirtz C, Vialaret J, Alcolea D, Lleó A, Fortea J, Santosh MS, Choubey S, Lehmann S. Detection of amyloid beta peptides in body fluids for the diagnosis of alzheimer's disease: Where do we stand? Crit Rev Clin Lab Sci 2020;57:99-113. [PMID: 31661652 DOI: 10.1080/10408363.2019.1678011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Gong X, Zhang H, Liu X, Liu Y, Liu J, Fapohunda FO, Lü P, Wang K, Tang M. Is liquid biopsy mature enough for the diagnosis of Alzheimer’s disease? Front Aging Neurosci 2022;14:977999. [DOI: 10.3389/fnagi.2022.977999] [Reference Citation Analysis]
2 Agraharam G, Saravanan N, Girigoswami A, Girigoswami K. Future of Alzheimer’s Disease: Nanotechnology-Based Diagnostics and Therapeutic Approach. BioNanoSci . [DOI: 10.1007/s12668-022-00998-8] [Reference Citation Analysis]
3 Kelkar N, Prabhu A, Prabhu A, Giri Nandagopal M, Mani NK. Sensing of body fluid hormones using paper-based analytical devices. Microchemical Journal 2022;174:107069. [DOI: 10.1016/j.microc.2021.107069] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
4 Allen AC, Efrem M, Mahalingam U, Guarino-Hotz M, Foley AR, Raskatov JA, Song C, Lindley SA, Li J, Chen B, Zhang JZ. Hollow Gold Nanosphere Templated Synthesis of PEGylated Hollow Gold Nanostars and Use for SERS Detection of Amyloid Beta in Solution. J Phys Chem B 2021;125:12344-52. [PMID: 34726922 DOI: 10.1021/acs.jpcb.1c06776] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Huckvale ED, Hodgman MW, Greenwood BB, Stucki DO, Ward KM, Ebbert MTW, Kauwe JSK, The Alzheimer's Disease Neuroimaging Initiative, The Alzheimer's Disease Metabolomics Consortium, Miller JB. Pairwise Correlation Analysis of the Alzheimer's Disease Neuroimaging Initiative (ADNI) Dataset Reveals Significant Feature Correlation. Genes (Basel) 2021;12:1661. [PMID: 34828267 DOI: 10.3390/genes12111661] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Hansen EO, Dias NS, Burgos ICB, Costa MV, Carvalho AT, Teixeira AL, Barbosa IG, Santos LAV, Rosa DVF, Ribeiro AJF, Viana BM, Bicalho MAC. Millipore xMap® Luminex (HATMAG-68K): An Accurate and Cost-Effective Method for Evaluating Alzheimer's Biomarkers in Cerebrospinal Fluid. Front Psychiatry 2021;12:716686. [PMID: 34531769 DOI: 10.3389/fpsyt.2021.716686] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Mikuła E. Recent Advancements in Electrochemical Biosensors for Alzheimer's Disease Biomarkers Detection. Curr Med Chem 2021;28:4049-73. [PMID: 33176635 DOI: 10.2174/0929867327666201111141341] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
8 Alcolea D, Delaby C, Muñoz L, Torres S, Estellés T, Zhu N, Barroeta I, Carmona-Iragui M, Illán-Gala I, Santos-Santos MÁ, Altuna M, Sala I, Sánchez-Saudinós MB, Videla L, Valldeneu S, Subirana A, Pegueroles J, Hirtz C, Vialaret J, Lehmann S, Karikari TK, Ashton NJ, Blennow K, Zetterberg H, Belbin O, Blesa R, Clarimón J, Fortea J, Lleó A. Use of plasma biomarkers for AT(N) classification of neurodegenerative dementias. J Neurol Neurosurg Psychiatry 2021:jnnp-2021-326603. [PMID: 34103344 DOI: 10.1136/jnnp-2021-326603] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
9 Oyarzún MP, Tapia-Arellano A, Cabrera P, Jara-Guajardo P, Kogan MJ. Plasmonic Nanoparticles as Optical Sensing Probes for the Detection of Alzheimer's Disease. Sensors (Basel) 2021;21:2067. [PMID: 33809416 DOI: 10.3390/s21062067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Xiong Y, Shi C, Li L, Tang Y, Zhang X, Liao S, Zhang B, Sun C, Ren C. A review on recent advances in amino acid and peptide-based fluorescence and its potential applications. New J Chem 2021;45:15180-94. [DOI: 10.1039/d1nj02230j] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
11 Zhao J, Chang W, Liu L, Xing X, Zhang C, Meng H, Gopinath SCB, Lakshmipriya T, Chen Y, Liu Y. Graphene oxide-gold nanoparticle-aptamer complexed probe for detecting amyloid beta oligomer by ELISA-based immunoassay. J Immunol Methods 2021;489:112942. [PMID: 33333060 DOI: 10.1016/j.jim.2020.112942] [Cited by in Crossref: 5] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
12 Van Thanh Nguyen N, Taverna M, Smadja C, Mai TD. Recent Electrokinetic and Microfluidic Strategies for Detection of Amyloid Beta Peptide Biomarkers: Towards Molecular Diagnosis of Alzheimer's Disease. Chem Rec 2021;21:149-61. [PMID: 33112020 DOI: 10.1002/tcr.202000103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
13 Lopes Alves I, Collij LE, Altomare D, Frisoni GB, Saint-Aubert L, Payoux P, Kivipelto M, Jessen F, Drzezga A, Leeuwis A, Wink AM, Visser PJ, van Berckel BNM, Scheltens P, Gray KR, Wolz R, Stephens A, Gismondi R, Buckely C, Gispert JD, Schmidt M, Ford L, Ritchie C, Farrar G, Barkhof F, Molinuevo JL; AMYPAD Consortium. Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study. Alzheimers Dement 2020;16:750-8. [PMID: 32281303 DOI: 10.1002/alz.12069] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
14 Mendes RF, Figueira F, Leite JP, Gales L, Almeida Paz FA. Metal–organic frameworks: a future toolbox for biomedicine? Chem Soc Rev 2020;49:9121-53. [DOI: 10.1039/d0cs00883d] [Cited by in Crossref: 35] [Cited by in F6Publishing: 62] [Article Influence: 17.5] [Reference Citation Analysis]